CME Newsletter #2

Progress in Practice: Special Considerations in the Management of Overactive Bladder
While much of the literature on overactive bladder (OAB) addresses the needs of women, the condition occurs equally in both sexes, and its prevalence increases with age. Although many OAB treatment strategies are available, some patients do not respond adequately to initial therapy, treatment selection for elderly patients can be challenging, and for all patients, the potential for adverse effects and drug-drug interactions must be minimized. This issue of The Urology University CME Newsletter presents an expert overview of these special considerations in OAB management. The authors review the workup of men with OAB symptoms, discuss the use of antimuscarinic agents in older adults, examine potential safety and tolerability issues associated with antimuscarinic agents, and offer management strategies for patients with refractory OAB. With an eye to the future, they also discuss investigational therapies that may have a role in the management of OAB.